Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 4395.0
(0.0%)
JPY 4395.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.03 Billion JPY | -9.1% |
| 2022 | 5.54 Billion JPY | 18.99% |
| 2021 | 4.65 Billion JPY | -1.73% |
| 2020 | 4.73 Billion JPY | 231.33% |
| 2019 | 1.43 Billion JPY | -71.12% |
| 2018 | 4.95 Billion JPY | -21.17% |
| 2017 | 6.28 Billion JPY | 64.47% |
| 2016 | 3.81 Billion JPY | -22.36% |
| 2015 | 4.91 Billion JPY | 22.0% |
| 2014 | 4.03 Billion JPY | -19.15% |
| 2013 | 4.98 Billion JPY | 78.49% |
| 2012 | 2.79 Billion JPY | -32.72% |
| 2011 | 4.15 Billion JPY | 125.22% |
| 2010 | 1.84 Billion JPY | -69.89% |
| 2009 | 6.12 Billion JPY | 25.03% |
| 2008 | 4.89 Billion JPY | -4.67% |
| 2007 | 5.13 Billion JPY | -58.0% |
| 2006 | 12.23 Billion JPY | 60.86% |
| 2005 | 7.6 Billion JPY | -10.51% |
| 2004 | 8.49 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 1.51 Billion JPY | -13.59% |
| 2024 Q2 | 1.75 Billion JPY | 27.02% |
| 2024 Q1 | 1.38 Billion JPY | -24.16% |
| 2023 Q3 | 1.7 Billion JPY | -12.63% |
| 2023 FY | 5.03 Billion JPY | -9.1% |
| 2023 Q4 | 1.82 Billion JPY | 7.29% |
| 2023 Q2 | 1.94 Billion JPY | 545.54% |
| 2023 Q1 | -437 Million JPY | -129.65% |
| 2022 Q3 | 1.38 Billion JPY | -0.43% |
| 2022 Q2 | 1.39 Billion JPY | 7.59% |
| 2022 FY | 5.54 Billion JPY | 18.99% |
| 2022 Q1 | 1.29 Billion JPY | -14.04% |
| 2022 Q4 | 1.47 Billion JPY | 6.5% |
| 2021 FY | 4.65 Billion JPY | -1.73% |
| 2021 Q4 | 1.5 Billion JPY | 10.11% |
| 2021 Q1 | 689 Million JPY | -41.86% |
| 2021 Q2 | 1.09 Billion JPY | 59.51% |
| 2021 Q3 | 1.36 Billion JPY | 24.2% |
| 2020 Q4 | 1.18 Billion JPY | 45.4% |
| 2020 Q1 | 1.25 Billion JPY | 63.02% |
| 2020 Q2 | 1.48 Billion JPY | 18.69% |
| 2020 Q3 | 815 Million JPY | -45.15% |
| 2020 FY | 4.73 Billion JPY | 231.33% |
| 2019 Q3 | 372 Million JPY | -62.76% |
| 2019 Q4 | 768 Million JPY | 106.45% |
| 2019 FY | 1.43 Billion JPY | -71.12% |
| 2019 Q1 | -709 Million JPY | -137.18% |
| 2019 Q2 | 999 Million JPY | 240.9% |
| 2018 Q3 | 935 Million JPY | -30.22% |
| 2018 FY | 4.95 Billion JPY | -21.17% |
| 2018 Q1 | 769 Million JPY | -70.66% |
| 2018 Q4 | 1.9 Billion JPY | 103.96% |
| 2018 Q2 | 1.34 Billion JPY | 74.25% |
| 2017 Q2 | 1.83 Billion JPY | 244.84% |
| 2017 FY | 6.28 Billion JPY | 64.47% |
| 2017 Q4 | 2.62 Billion JPY | 103.34% |
| 2017 Q3 | 1.28 Billion JPY | -29.87% |
| 2017 Q1 | 533 Million JPY | -57.19% |
| 2016 Q2 | 1.03 Billion JPY | -12.75% |
| 2016 Q1 | 1.18 Billion JPY | -16.91% |
| 2016 FY | 3.81 Billion JPY | -22.36% |
| 2016 Q4 | 1.24 Billion JPY | 248.74% |
| 2016 Q3 | 357 Million JPY | -65.44% |
| 2015 FY | 4.91 Billion JPY | 22.0% |
| 2015 Q4 | 1.42 Billion JPY | 37.95% |
| 2015 Q3 | 1.03 Billion JPY | -39.8% |
| 2015 Q2 | 1.71 Billion JPY | 130.34% |
| 2015 Q1 | 745 Million JPY | 0.0% |
| 2014 Q3 | 1.63 Billion JPY | 138.54% |
| 2014 Q1 | 1 Billion JPY | -27.73% |
| 2014 FY | 4.03 Billion JPY | -19.15% |
| 2014 Q2 | 685 Million JPY | -31.57% |
| 2013 Q4 | 1.38 Billion JPY | 8.2% |
| 2013 FY | 4.98 Billion JPY | 78.49% |
| 2013 Q1 | -365 Million JPY | -134.05% |
| 2013 Q2 | 1.32 Billion JPY | 461.92% |
| 2013 Q3 | 1.28 Billion JPY | -3.1% |
| 2012 Q4 | 1.07 Billion JPY | 11.55% |
| 2012 FY | 2.79 Billion JPY | -32.72% |
| 2012 Q1 | -6.28 Billion JPY | -241.94% |
| 2012 Q2 | 1.12 Billion JPY | 117.92% |
| 2012 Q3 | 961 Million JPY | -14.65% |
| 2011 FY | 4.15 Billion JPY | 125.22% |
| 2011 Q2 | 3.47 Billion JPY | 164.96% |
| 2011 Q3 | 2.54 Billion JPY | -26.63% |
| 2011 Q4 | 4.42 Billion JPY | 73.92% |
| 2011 Q1 | -5.34 Billion JPY | -235.48% |
| 2010 Q2 | 3.99 Billion JPY | 307.27% |
| 2010 FY | 1.84 Billion JPY | -69.89% |
| 2010 Q4 | 3.94 Billion JPY | 12.56% |
| 2010 Q3 | 3.5 Billion JPY | -12.25% |
| 2010 Q1 | -1.92 Billion JPY | -143.64% |
| 2009 Q1 | -6.9 Billion JPY | -222.65% |
| 2009 Q2 | 3.96 Billion JPY | 157.35% |
| 2009 Q3 | 3.92 Billion JPY | -0.98% |
| 2009 Q4 | 4.41 Billion JPY | 12.55% |
| 2009 FY | 6.12 Billion JPY | 25.03% |
| 2008 Q4 | 5.63 Billion JPY | 73.87% |
| 2008 Q3 | 3.23 Billion JPY | 0.0% |
| 2008 FY | 4.89 Billion JPY | -4.67% |
| 2007 FY | 5.13 Billion JPY | -58.0% |
| 2006 FY | 12.23 Billion JPY | 60.86% |
| 2005 FY | 7.6 Billion JPY | -10.51% |
| 2004 FY | 8.49 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 5.11 Billion JPY | 1.506% |
| Takeda Pharmaceutical Company Limited | 214.07 Billion JPY | 97.648% |
| Sumitomo Pharma Co., Ltd. | -354.19 Billion JPY | 101.422% |
| Shionogi & Co., Ltd. | 171.46 Billion JPY | 97.063% |
| Wakamoto Pharmaceutical Co.,Ltd. | -195.51 Million JPY | 2675.814% |
| Nippon Shinyaku Co., Ltd. | 31.38 Billion JPY | 83.955% |
| Kaken Pharmaceutical Co., Ltd. | 9.51 Billion JPY | 47.062% |
| Eisai Co., Ltd. | 53.4 Billion JPY | 90.571% |
| Morishita Jintan Co., Ltd. | 716 Million JPY | -603.352% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.16 Billion JPY | 61.753% |
| Mochida Pharmaceutical Co., Ltd. | 5.8 Billion JPY | 13.217% |
| Fuso Pharmaceutical Industries,Ltd. | 1.96 Billion JPY | -156.415% |
| Nippon Chemiphar Co., Ltd. | -494 Million JPY | 1119.433% |
| Tsumura & Co. | 20.01 Billion JPY | 74.843% |
| Kissei Pharmaceutical Co., Ltd. | 4.01 Billion JPY | -25.367% |
| Towa Pharmaceutical Co., Ltd. | 17.64 Billion JPY | 71.464% |
| Fuji Pharma Co., Ltd. | 3.85 Billion JPY | -30.534% |
| Zeria Pharmaceutical Co., Ltd. | 9.71 Billion JPY | 48.171% |
| KYORIN Holdings, Inc. | 6.01 Billion JPY | 16.248% |
| Taiko Pharmaceutical Co.,Ltd. | -3.07 Billion JPY | 263.56% |
| Daito Pharmaceutical Co.,Ltd. | 3.89 Billion JPY | -29.327% |
| SymBio Pharmaceuticals Limited | -811.66 Million JPY | 720.451% |
| MedRx Co., Ltd | -933 Million JPY | 639.764% |
| Mizuho Medy Co.,Ltd. | 5.15 Billion JPY | 2.251% |
| Solasia Pharma K.K. | -1.13 Billion JPY | 542.142% |
| Modalis Therapeutics Corporation | -2.37 Billion JPY | 312.489% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 6.5 Billion JPY | 22.523% |
| Sawai Group Holdings Co., Ltd. | 18.88 Billion JPY | 73.335% |
| Cyfuse Biomedical K.K. | -697.43 Million JPY | 822.072% |
| Toho Holdings Co., Ltd. | 19.33 Billion JPY | 73.949% |
| Koa Shoji Holdings Co.,Ltd. | 4.38 Billion JPY | -14.916% |